385 related articles for article (PubMed ID: 21471573)
1. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
3. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
[TBL] [Abstract][Full Text] [Related]
4. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals.
Volz T; Nega M; Buschmann J; Kaesler S; Guenova E; Peschel A; Röcken M; Götz F; Biedermann T
FASEB J; 2010 Oct; 24(10):4089-102. PubMed ID: 20522786
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors?
Macho Fernandez E; Pot B; Grangette C
Gut Microbes; 2011 Sep; 2(5):280-6. PubMed ID: 22067939
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory lactobacilli: strain specificity.
Matuchansky C
Gut; 2012 May; 61(5):786; author reply 784. PubMed ID: 21846781
[No Abstract] [Full Text] [Related]
8. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
9. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.
Boirivant M; Amendola A; Butera A; Sanchez M; Xu L; Marinaro M; Kitani A; Di Giacinto C; Strober W; Fuss IJ
Gastroenterology; 2008 Nov; 135(5):1612-1623.e5. PubMed ID: 18765239
[TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
11. CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis.
Heiseke AF; Faul AC; Lehr HA; Förster I; Schmid RM; Krug AB; Reindl W
Gastroenterology; 2012 Feb; 142(2):335-45. PubMed ID: 22057112
[TBL] [Abstract][Full Text] [Related]
12. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
13. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
14. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
[TBL] [Abstract][Full Text] [Related]
15. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B
Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197
[TBL] [Abstract][Full Text] [Related]
16. A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.
Matsumoto S; Hara T; Nagaoka M; Mike A; Mitsuyama K; Sako T; Yamamoto M; Kado S; Takada T
Immunology; 2009 Sep; 128(1 Suppl):e170-80. PubMed ID: 19740306
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
[TBL] [Abstract][Full Text] [Related]
18. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
19. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.
Hofmann C; Dunger N; Grunwald N; Hämmerling GJ; Hoffmann P; Schölmerich J; Falk W; Obermeier F
Gut; 2010 Oct; 59(10):1347-54. PubMed ID: 20732920
[TBL] [Abstract][Full Text] [Related]
20. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]